+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Phase 3
Age: 18Years +
All Genders
ID06011889

A Randomized, Double-Blind Study Comparing Etanercept and Placebo for Treating Adults With SAPHO Syndrome

Led by National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland · Updated on 2026-04-13

60

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the treatment of SAPHO syndrome, a rare condition characterized by skin and bone inflammation, in adults who have not responded well to standard therapies. This trial evaluates the effects of adding etanercept, a drug, compared to a placebo, both alongside ongoing non-steroidal anti-inflammatory drugs NSAIDs andor classic disease-modifying antirheumatic drugs DMARDs. The study aims to better understand how etanercept might reduce disease activity and pain in this patient group. Participants are randomly assigned to receive either etanercept plus their current stable NSAID andor DMARD treatment or a placebo with the same background treatments. The study is double-blind, meaning neither the participants nor the researchers know who receives the active drug or placebo during the 12-week treatment period. The main treatment phase focuses on assessing changes in disease activity and pain using patient-reported scales. During the study, participants will be carefully monitored through regular assessments at 4, 8, and 12 weeks. These include patient and physician evaluations of disease activity, measurement of inflammation markers like C-reactive protein and erythrocyte sedimentation rate, quality of life surveys, and work productivity questionnaires. The primary outcome is a 50% or greater reduction in disease activity and pain after 12 weeks. Safety and treatment effects will be followed throughout the study period, which extends until October 2028.

CONDITIONS

Brief Title

Study of the Efficacy and Safety of Etanercept Treatment in Patients With SAPHO Syndrome

Research Team

J

Jakub Wroński, PhD, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here